Literature DB >> 12492571

Novel therapies for multiple myeloma.

Toshiaki Hayashi1, Teru Hideshima, Kenneth C Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12492571     DOI： 10.1046/j.1365-2141.2003.03929.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  15 in total

1.  Novel therapy in multiple myeloma.

Authors:  Agustin Avilés; Natividad Neri; M Jesús Nambo; Sergio Cleto; Claudia Castañeda; Martha González; Alejandra Talavera; Judith Huerta-Guzmán
Journal:  Invest New Drugs       Date:  2005-10       Impact factor: 3.850

2.  Adoptive cellular therapy using cells enriched for NKG2D+CD3+CD8+T cells after autologous transplantation for myeloma.

Authors:  Kenneth R Meehan; Laleh Talebian; Tor D Tosteson; John M Hill; Zbigniew Szczepiorkowski; Charles L Sentman; Marc S Ernstoff
Journal:  Biol Blood Marrow Transplant       Date:  2012-09-10       Impact factor: 5.742

3.  A quantitative microfluidic angiogenesis screen for studying anti-angiogenic therapeutic drugs.

Authors:  Choong Kim; Junichi Kasuya; Jessie Jeon; Seok Chung; Roger D Kamm
Journal:  Lab Chip       Date:  2015-01-07       Impact factor: 6.799

4.  Combined treatment with EGFR inhibitors and arsenite upregulated apoptosis in human EGFR-positive melanomas: a role of suppression of the PI3K-AKT pathway.

Authors:  Vladimir N Ivanov; Tom K Hei
Journal:  Oncogene       Date:  2005-01-20       Impact factor: 9.867

5.  Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer.

Authors:  Spyridon Marinopoulos; Lamprini Skorda; Stylianos Karatapanis; Antonis Rasidakis
Journal:  Med Oncol       Date:  2008-03-15       Impact factor: 3.064

6.  Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.

Authors:  Vladimir N Ivanov; Tom K Hei
Journal:  Exp Cell Res       Date:  2006-02-17       Impact factor: 3.905

Review 7.  Therapy strategies for multiple myeloma: current status.

Authors:  Heinz Gisslinger; Mathias Kees
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

8.  Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma.

Authors:  Jae-Cheol Jo; Byung Woog Kang; Sun Jin Sym; Sung Sook Lee; Geundoo Jang; Shin Kim; Dae Ho Lee; Sang-We Kim; Jung Shin Lee; Cheolwon Suh
Journal:  Invest New Drugs       Date:  2009-10-13       Impact factor: 3.850

9.  Arsenite sensitizes human melanomas to apoptosis via tumor necrosis factor alpha-mediated pathway.

Authors:  Vladimir N Ivanov; Tom K Hei
Journal:  J Biol Chem       Date:  2004-03-17       Impact factor: 5.157

10.  Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells.

Authors:  Barbara Zdzisińska; Agnieszka Bojarska-Junak; Anna Dmoszyńska; Martyna Kandefer-Szerszeń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-05-30       Impact factor: 4.291
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.